ZYVERSA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Increase (Decrease) in Prepaid Expense of -$193.24 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-11-14
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was -$57.01K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-06-30 was -$61.56K.
- ZYVERSA THERAPEUTICS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-03-31 was -$74.67K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month |
|---|---|---|---|
| 2022-09-30 | -$57.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$118.57K derived: sum of 2 quarters · filed 2022-11-14 | -$193.24K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$61.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$136.23K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$74.67K 10-Q · filed 2022-05-13 | ||
| 2021-12-31 | $464.97K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |